https://www.selleckchem.com/pr....oducts/brensocatib.h
To evaluate the incidence of facial canal dehiscence (FCD) and other intraoperative findings over the last 20 years as well as correlation with the Japanese Otological Society/European Academy of Otology and Neurotology classification in patients with cholesteatoma. A total of 469 patients operated from 1998 to 2018 were selected and divided into 2 groups of 10 years each. Dehiscence was significantly higher in patients with a history of pathology longer than 5 years (22.7%). Higher values were observed in revision surgery, 44.4% in
Like
Comment
Share
